News & Updates
Filter by Specialty:
Obesity ups risk of early-onset colorectal cancer
Obese people are more likely to develop early-onset colorectal cancer (CRC), suggests a study, noting that the increasing prevalence of obesity in younger generations may significantly contribute to the increase in this disease.
Obesity ups risk of early-onset colorectal cancer
22 Nov 2021
Long-term TAF works against resistant HBV, poses no excess cardiovascular risk
Tenofovir alafenamide (TAF) shows sustained safety and efficacy in heavily pretreated patients with multidrug-resistant hepatitis B virus (HBV) through 3 years of treatment, albeit leading to elevations in cholesterol levels.
Long-term TAF works against resistant HBV, poses no excess cardiovascular risk
17 Nov 2021
Statins reduce hepatocellular carcinoma risk in cirrhotic patients
The risk of hepatocellular carcinoma (HCC) among patients with nonalcoholic steatohepatitis (NASH) and bridging fibrosis is low, reveals a recent study. In addition, dose-dependent statin can substantially lower the risk of HCC in patients with NASH cirrhosis.
Statins reduce hepatocellular carcinoma risk in cirrhotic patients
17 Nov 2021
Pandemic burnout hounds hepatology providers
Burnout is experienced by nearly half (~40 percent) of hepatology providers during the COVID-19 pandemic, as shown by the negative impact of emotional well-being, including work fulfilment and satisfaction, according to a study.
Pandemic burnout hounds hepatology providers
17 Nov 2021
Is peppermint oil good for individuals with irritable bowel syndrome?
Peppermint oil appears to significantly improve symptoms of irritable bowel syndrome (IBS), as does placebo, with no significant differences between groups, reports a study.